Aseptic Filling Operations To Keep In-House Or Outsource
Pouring millions into the infrastructure and quality systems necessary to move away from manual filling is unrealistic and detracts from your strengths in drug development.
Aseptic Filling Operations To Keep In-House Or Outsource Get more Bioprocess insight with our FREE newsletter sign me up Log In or Subscribe Article | September 23, 2020 Aseptic Filling Operations – To Keep In-House Or Outsource? Source: JOINN Biologics For decades, competitive innovations have been driving the sizes of devices smaller and the prices lower. This has been clearly achieved in computer tech with advances in microchips, and the same has been developing in the biotech equipment industry with both analytical test equipment and drug manufacturing equipment, making them more accessibl
Explore this link on the map →related reading
- Tech vs Biotech - Celine Haliouacelinehh.com
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- To grow your business, you have to make big betsramp.com
- Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
- The Machine Behind Every Exceptional Sip | Overpotentialoverpotential.com
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- Astro Mechanica - Not Boring by Packy McCormicknotboring.co
- Barrels and Ammunition | Conor Deweyconordewey.com
- The Age of Tech x Bio: The 'Industrial Bio Complex' | Andreessen Horowitza16z.com
- Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio
- Biotech’s Lost Archive | IFPifp.org
- Full-Stack Startups in American Dynamism | Andreessen Horowitza16z.com